Phase II trial of a sequential regimen of induction chemotherapy with panitumumab and paclitaxel followed by radiotherapy plus panitumumab in patients with head and neck cancer, locally advanced non-candidates for treatment with platinum.
Phase of Trial: Phase II
Latest Information Update: 04 Feb 2013
At a glance
- Drugs Panitumumab (Primary) ; Paclitaxel
- Indications Head and neck cancer
- Focus Therapeutic Use
- Acronyms PANTERA
- 04 Feb 2013 Planned number of patients changed to 61.
- 04 Feb 2013 New trial record